Halozyme Therapeutics, Inc. (LON:0J2O)
London
· Delayed Price · Currency is GBP · Price in USD 52.87
-0.22 (-0.41%)
At close: Jun 20, 2025
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of 4.83 billion as of June 20, 2025. Its market cap has increased by 7.76% in one year.
Market Cap
4.83B
Enterprise Value
5.42B
Revenue
839.24M
Ranking
n/a
PE Ratio
12.86
Stock Price
52.87
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 95.57M to 4.83B, an increase of 4,954.84%. That is a compound annual growth rate of 20.42%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 163.63B |
| GSK plc | 58.11B |
| Haleon | 34.38B |
| Smith & Nephew | 9.40B |
| ConvaTec Group | 5.72B |
| Hikma Pharmaceuticals | 4.53B |
| HUTCHMED (China) | 1.88B |
| Indivior | 1.30B |